Download
s13063-020-04626-2.pdf 825,31KB
WeightNameValue
1000 Titel
  • Substitution of perioperative albumin deficiency disorders (SuperAdd) in adults undergoing vascular, abdominal, trauma, or orthopedic surgery: protocol for a randomized controlled trial
1000 Autor/in
  1. Schaller, Stefan J. |
  2. Fuest, Kristina |
  3. Ulm, Bernhard |
  4. Schmid, Sebastian |
  5. Bubb, Catherina |
  6. von Eisenhart-Rothe, Rüdiger |
  7. Friess, Helmut |
  8. Kirchhoff, Chlodwig |
  9. Stadlbauer, Thomas |
  10. Luppa, Peter |
  11. Blobner, Manfred |
  12. Jungwirth, Bettina |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-08-18
1000 Erschienen in
1000 Quellenangabe
  • 21(1):726
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13063-020-04626-2 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433099/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Hypalbuminemia is associated with numerous postoperative complications, so a perioperative albumin substitution is often considered. The objective of SuperAdd is to investigate whether substitution of human albumin, aiming to maintain a serum concentration > 30 g/l, can reduce postoperative complications in normovolemic surgical patients in comparison with standard care.!##!Methods/design!#!SuperAdd is a single-center, prospective, randomized, outcome-assessor blinded, patient blinded controlled trial. The primary outcome is the frequency of postoperative complications identified using the Postoperative Morbidity Survey graded ≥ 2 according to the Clavien-Dindo Score. Adult patients at risk to develop hypalbuminemia, i.e., ASA III or IV or high-risk surgery, are recruited after written informed consent was obtained. The albumin concentration is assessed before the induction of anesthesia and every 3 h until admission to the postanesthesia care unit. If albumin concentrations drop below 30 g/l, patients are randomly allocated to the control or the treatment group. The study intervention is a goal-directed human albumin substitution aimed at a concentration > 30 g/l during surgery and postanesthesia care unit stay. The patients in the control group are treated according to standard clinical care. Postoperative visits are to be performed on days 1, 3, 5, 8, and 15, as well as by telephone 6 months after surgery.!##!Discussion!#!SuperAdd is the first clinical trial in a surgical population investigating the effect of a goal-directed albumin substitution aiming at a serum level > 30 g/l. The nonrestrictive selection of patients guarantees that the patients without albumin screening will most likely not develop hypalbuminemia, thus ensuring generalizability of the study results.!##!Trial registration!#!EudraCT 2016-001313-24. Registered on 5 September 2016. Clinical Trials NCT03167645. Registered on 18 October 2016 and has the Universal Trial Number (UTN) U1111-1181-2625.
1000 Sacherschließung
lokal Postoperative complications
lokal Adult [MeSH]
lokal Study Protocol
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Hypoalbuminemia/prevention
lokal Serum albumin
lokal Abdomen/surgery [MeSH]
lokal Hypalbuminemia
lokal Randomized Controlled Trials as Topic [MeSH]
lokal Orthopedic Procedures [MeSH]
lokal Postoperative Complications/prevention
lokal Wounds and Injuries/surgery [MeSH]
lokal Perioperative care
lokal Albumins/administration
lokal Postoperative Complications/etiology [MeSH]
lokal Postoperative care
lokal Vascular Surgical Procedures [MeSH]
lokal Serum Albumin, Human [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2NoYWxsZXIsIFN0ZWZhbiBKLg==|https://frl.publisso.de/adhoc/uri/RnVlc3QsIEtyaXN0aW5h|https://frl.publisso.de/adhoc/uri/VWxtLCBCZXJuaGFyZA==|https://frl.publisso.de/adhoc/uri/U2NobWlkLCBTZWJhc3RpYW4=|https://frl.publisso.de/adhoc/uri/QnViYiwgQ2F0aGVyaW5h|https://frl.publisso.de/adhoc/uri/dm9uIEVpc2VuaGFydC1Sb3RoZSwgUsO8ZGlnZXI=|https://frl.publisso.de/adhoc/uri/RnJpZXNzLCBIZWxtdXQ=|https://frl.publisso.de/adhoc/uri/S2lyY2hob2ZmLCBDaGxvZHdpZw==|https://frl.publisso.de/adhoc/uri/U3RhZGxiYXVlciwgVGhvbWFz|https://frl.publisso.de/adhoc/uri/THVwcGEsIFBldGVy|https://orcid.org/0000-0002-0370-5247|https://frl.publisso.de/adhoc/uri/SnVuZ3dpcnRoLCBCZXR0aW5h
1000 Hinweis
  • DeepGreen-ID: 3e79471c41a747699484023384474273 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6463115.rdf
1000 Erstellt am 2023-11-15T16:39:53.411+0100
1000 Erstellt von 322
1000 beschreibt frl:6463115
1000 Zuletzt bearbeitet 2023-11-30T21:03:32.040+0100
1000 Objekt bearb. Thu Nov 30 21:03:32 CET 2023
1000 Vgl. frl:6463115
1000 Oai Id
  1. oai:frl.publisso.de:frl:6463115 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source